About the Report
Real-time bioprocess raman analyzers are devices that incorporate Raman spectroscopy as a vibration / optical spectroscopy procedure that provides chemical and physical "molecular fingerprints" for the sample. Raman spectroscopy enables a complete understanding of bioprocess and real-time control of nutrients and metabolites. Raman spectroscopy has a wide range of features due to new technological advances, simple methods of data analysis models, and other Real-time Bioprocess Raman Analyzer applications.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights offers insights about key factors driving demand for real-time bioprocess Raman Analyzers. The report tracks global sales of real-time bioprocess raman analyzers in 15 high-growth markets, where major traction is being witnessed in North America, followed by Europe.
Future Outlook For Realtime Bioprocess Raman Analyzer Market Looks Brighter Historic Sales
Initiatives by the government encouraging investment in research and development (R&D) and boosting healthcare expenditure are expected to fuel the demand for real-time bioprocess Raman Analyzers. The Food and Drugs Organization (FDA) and other international organizations are emphasizing on the use of PAT technology used by real-time bioprocess Raman Analyzers for the manufacturing of high-quality biopharmaceuticals and to increase the rate of production by automating the process and using less manual interference in the bioprocessing.
Technological advancements and mergers and acquisitions undertaken by leading market players will bode well for the market. For instance, in 2020 Merck KGaA has announced its decision to acquire Resolution Spectra Systems Inc. leading to market expansion for real-time bioprocess Raman Analyzers. According to Future Market Insights, adoption of these strategies has enabled expansion at 6.2% from 2018 to 2019.
The developed nations have actively adopted real-time bioprocess Raman Analyzers and markets within these countries have been exhibiting steady growth. However, emerging nations are yet to adopt these analyzers on a large scale primarily due to the lack of information and low GDP and healthcare expenditure of the region. This lack of information and the high cost of the product has majorly impacted the real-time bioprocess Raman Analyzers market. COVID 19 has led to large-scale closures of manufacturing units and disruption in supply chain activities impacting the market growth, albeit for a short duration of time. Future Market Insights has projected the market to progress at an impressive 14.6% CAGR through 2030.
How are Regulations Favoring Real-time bioprocess Raman Analyzers Market Growth?
Regulatory bodies are continuously trying to create favorable scenarios for the development and commercialization of real-time bioprocess Raman Analyzers owing to producing high-quality biopharmaceutical products. These regulatory bodies have enforced the use of Process Analytical Technology in real-time bioprocess Raman Analyzers for further speeding up the bioprocess and automating the data processing during the process.
Country-wise Insights
How big is the Opportunity in the U.S for Real-time bioprocess Raman Analyzers?
Future Market Insights has projected the U.S. to remain the most lucrative market throughout the forecast period. One of the key factors supporting market expansion is a large number of bioprocessing companies and contract manufacturing organizations. Also, the healthcare infrastructure in the U.S makes it the most lucrative market for real-time bioprocess Raman Analyzers. The market in the U.S. is expected to progress at a significant CAGR of over 14% during the forecast period.
What is Driving Real-time bioprocess Raman Analyzers Sales in China?
While lack of awareness is identified as a chief restrain, increasing expenditure towards healthcare expansion will push growth in China. The country has observed a significant growth in health expenditure, which accounted for nearly 6% GDP of 6% in the last decade. China remains the second most attractive region for market growth of real-time bioprocess Raman Analyzers and is expected to grow at a CAGR of 18.9% during the forecast period owing to the presence of a large number of contract manufacturing organizations.
What is Supporting Realtime Bioprocess Market Expansion in Japan?
According to The World Bank Japan had spent 10.95% of GDP on healthcare in 2018. On account of increasing healthcare expenditure and rising focus on advanced healthcare technologies, FMI projects the Japan market to grow at a CAGR of more than 11% over the forecast period. While presence of a limited number of contract manufacturing organizations is thought to be a key restraint, but over the years the sector has exhibited incremental growth.
Emergence of a strong contract development and manufacturing industry has been enabling the market gain traction. For instance, Ajinomoto acquired Osaka-based GeneDesign in 2017, is now completely integrated with previously acquired Belgium-based Ajinomoto OmniChem and San Diego-based Althea to form Ajinomoto Bio-Pharma Services.
Also in 2019, Japanese contract research organization, CMIC CMO Co., LTD, announced about its collaboration with privately held Aprecia Pharmaceuticals, LLC to boost its manufacturing operations. Not to be excluded, the acquisition of Biogen (Denmark) Manufacturing ApS, which is a large scale biologics manufacturing site by FUJIFILM.
These developments are indicative of internationalization of Japan’s contract manufacturing scenario. This will pave way for the expansion of realtime bioprocess market within the country.
What is the Contribution of U.K. towards Real-time bioprocess Raman Analyzers Market?
The U.K. has emerged as a primary market for real-time bioprocess Raman Analyzers due to its growing GDP and expanding healthcare infrastructure. The availability of skilled labor is expected to aid overall expansion. The country’s pharmaceutical sector forms a combined turnover of £31.8bn, as per a report by HealthTech and Medicines Knowledge Transfer Network (Health KTN) and IfM Education and Consultancy Services Ltd, based at the University of Cambridge Institute for Manufacturing.
Growth of the pharmaceutical and biopharmaceutical sectors in the country is supported by various favorable government initiatives. In January 2010, for instance, the U.K. government introduced various plans for Life Science Super Cluster, bringing together NHS, industry, and academia to collaborate on early-stage clinical trials and experimental medicines. Such initiatives will augur well for the market, creating lucrative growth opportunities.
How attractive is the India Market for Real-time bioprocess Raman Analyzers?
There has been a significant rise in the number of domestic pharmaceutical manufacturing players in past few years in India. Indian pharmaceutical industry is said to rank 3rd based on the volume of biopharmaceutical products manufactured. India market backed by a high population is expected to register impressive growth in the real-time bioprocess Raman Analyzers market. Leading players operating here are attracted towards investing or collaborating with contract manufacturing organizations in India due to less labor cost and high manufacturing capacities.
From the past decade India has also observed increasing contribution of GDP towards healthcare and developing healthcare infrastructure. Hence, India with the increasing biopharmaceutical manufacturing and bioprocessing activities is expected to observe significant growth of the market dealing with real-time bioprocess Raman Analyzers.
Share of component type and application differs in key markets, the following chart presents the elucidated view of the component type share concerning key regions. In the top 4 regions which include North America, Europe, Asia Pacific and the Rest of World, the share of North America is significantly high, in comparison to other regions. Among component types, Raman Analyzers accounts for the leading share of the market. Raman Probes is also a major part of real-time bioprocess Raman Analyzers, and it holds the second position in terms of demand across all key regions.
Category-wise Insights
Why is Raman Analyzers highly Sought-after in Real-time bioprocess Raman Analyzers?
Raman analyzer accounts for over 70% of the global share among component types through the forecast period. This is due to the increasing demand for Raman spectroscopy solutions and data processing in real-time. Raman spectroscopy has led to the automation of data processing and thus speeding up the bioprocessing and data analysis. Hence Raman Analyzers hold the majority of revenue share for the real-time bioprocess Raman Analyzers market.
What is the Key Realtime Bioprocess Raman Analyzer Application?
The demand for realtime bioprocess raman analyzer is considerably high in bioprocess analysis segment. Accounting for over 70% of the market in terms of application, bioprocess analysis is forecast to remain dominant through the course of the forecast period.
Why are the Contract Manufacturing Organizations Leading?
Revenue from contract manufacturing organizations is expected to increase at a CAGR of more than 15% in the forecasted period. Increasing bioprocessing in contract manufacturing organizations is expected to boost demand for real-time bioprocess Raman Analyzers during the forecast period.
There have been significant funds allocation towards improving healthcare infrastructure in developing regions. This has led to the increasing production of bioprocessing and biopharmaceutical products across the globe, benefitting the real-time bioprocess Raman Analyzers market. Hence, clinical innovation, financial incentives, and improved healthcare infrastructure will increase the growth opportunities.
Competitive Landscape
Leading market players are focusing on expanding their product portfolio and global expansion along with undertaking mergers and acquisitions to gain competitive edge. For instance, in July 2020, Merck KGaA acquired Resolution Spectra Systems and also launched Bio4C ™ Software Suite which will allow the integration of enhanced process and digital technologies to advance process speed, quality and flexibility, while reducing costs.
Some of the leading companies operating in the market are:
- Kaiser Optical Systems (Endress+Hauser)
- Resolution Spectra Systems Inc. (Merck KGaA)
- Tornado Spectral Systems
- Sartorius AG
*Full competitive intelligence with SWOT analysis available in the report.
Scope of Report
| Attribute | Details |
| Forecast Period | 2020-2030 |
| Historical Data Available for | 2015-2019 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America, Europe, Asia Pacific and Rest of World |
| Key Countries Covered | U.S., Canada, Brazil, U.K., Germany, France, Italy, Spain, Switzerland, BENELUX, Rest of Europe, India, China, Japan, Rest of APAC |
| Key Segments Covered | Component Type, Application, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing |
Key Questions Answered in Report
-
Which is the most lucrative market for real-time bioprocess Raman Analyzers?
The North America real-time bioprocess Raman Analyzers market currently holds dominance. The U.S. currently leads the North America real-time bioprocess Raman Analyzers, backed by the presence of a sophisticated healthcare infrastructure.
-
Which is the preferred component type in real-time bioprocess raman analyzers market?
Raman analyzers are expected to remain the most lucrative segment among component types, driven by the increasing demand for Raman spectroscopy and Process Analytical Technology along with QbD.
-
Which are some of the leading companies offering real-time bioprocess Raman Analyzers?
Some of the leading companies offering real-time bioprocess Raman Analyzers are Kaiser Optical Systems (Endress+Hauser), Resolution Spectra Systems Inc. (Merck KGaA), Tornado Spectral Systems, Sartorius AG.
-
Which is the key application of real-time bioprocess Raman Analyzers?
Bioprocess analysis is expected to dominate the real-time bioprocess Raman Analyzers market over the forecast period as key application segment.
-
Which end-user is driving revenue of real-time bioprocess Raman Analyzers market?
Contract Manufacturing Organizations is expected to dominate the real-time bioprocess Raman Analyzers market over the forecast period. Along with biopharmaceutical companies showing significant growth of more than 13% during the forecast period.
Enquiry before Buying
Is this research conducted by Future Market Insights?
Yes, the research has been conducted by expert analysts of Future Market Insights, through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Future Market Insights?
Future Market Insights follows a methodology that encompasses the demand-side assessment of the market and triangulates the same through supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions. Request a detailed methodology.
Who are the respondents for primary research?
Future Market Insights speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
What are the sources of secondary research?
Future Market Insights conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.
How can I buy this report?
Future Market Insights provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely.
Real-time bioprocess Raman Analyzers Market by Category
Component Type
- Instruments
- Raman Analyzers
- Raman Probes
- Software
Application
- Lab to Process Analysis
- Bioprocess Analysis
End User
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Research Organizations
Region
- North America
- Europe
- Asia Pacific
- Rest of World
Need specific information?
In the news
by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights
Our Clients
View Our Reports from Healthcare
View Reports